Express Scripts Holding Co.

Ventyx valuation clears $1B, plus AstraZeneca, bluebird, Pfizer, Merck and more

Plus: Ocular, Genprex, SAB and more

With the approval of Oxlumo to treat primary hyperoxaluria, Alnylam is aiming to accelerate patient access to the ultra-rare disease therapy by building on the performance- and prevalence-based

Evrysdi from Genentech, PTC is approved for children and adults, will be priced lower than other SMA drugs

CVS is answering the call to decrease the cost burden of diabetes medications on patients

Express Scripts’ first digital formulary sets evidence bar for reimbursement

Back to School Part 4: Digital health will call for a new set of first principles for clinical development